Huiping Guan

Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.

G. Joberty, N. Zinn, M. Cheung, 2018, ACS medicinal chemistry letters.

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering.

David A. Scott, S. Kazmirski, A. Ferguson, 2015, Bioorganic & medicinal chemistry letters.

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

C. Liang, J. Cherrington, S. Vasile, 2006, Molecular Cancer Therapeutics.

Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase.

Robert A Blake, Chris Liang, C. Liang, 2004, Bioorganic & medicinal chemistry letters.

Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors.

M. Lamb, Stephanos Ioannidis, Michelle L Lamb, 2010, Bioorganic & medicinal chemistry letters.